Viewing data from:

HYDROXYZINE PAMOATE

ANDA

HYDROXYZINE PAMOATE | A088487 | BARR LABORATORIES LLC (AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC)

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: VISTARIL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.0822

per ea

Lowest NADAC/Unit

$0.0822

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60687070701HYDROXYZINE PAM 50 MG CAP	$0.0822	EA	Generic	—	2026-06-17
60687070765HYDROXYZINE PAM 50 MG CAP	$0.0822	EA	Generic	—	2026-06-17
00555030202HYDROXYZINE PAM 50 MG CAP	$0.0822	EA	Generic	—	2026-06-17
00555030204HYDROXYZINE PAM 50 MG CAP	$0.0822	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$19.40

Highest Price

$95.05

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00555-0302-02HYDROXYZINE PAMOATE 50MG CAP	$19.40	FSS	AvKare, LLC	06/14/2028
00555-0302-04HYDROXYZINE PAMOATE 50MG CAP	$95.05	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

COSMA SPAHYDROXYZINE PAMOATE

DMF 45141982

IPCA LABORATORIES LTDHYDROXYZINE PAMOATE USP

DMF 369542022

SYMED LABS LTDHYDROXYZINE PAMOATE USP

DMF 385352023

EMCURE PHARMACEUTICALS LTDHYDROXYZINE PAMOATE USP

DMF 409772024

COHANCE LIFESCIENCES LTDHYDROXYZINE PAMOATE USP

DMF 427772025

INDUSTRIA CHIMICA PROFARMACO SPAInactiveHYDROXYZINE PAMOATE

DMF 28081976

UCB PHARMACEUTICALS INCInactiveHYDROXYZINE PAMOATE

DMF 36951980

CHEMI SPAInactiveHYDROXYZINE PAMOATE USP. XX

DMF 46291982

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 50MG HYDROCHLORIDE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jun 15, 1984

No patent or exclusivity listings for this strength.